AIDS. 24():S81–S92, OCTOBER 2010

DOI: 10.1097/01.aids.0000390710.04255.2b

,  

PMID: 21042056

Issn Print: 0269-9370

Publication Date: October 2010


Share this on facebook   Share this on Twitter   Share this on LinkedIn   Email this article  



Print

HIV prevention research: taking stock and the way forward

Richard Hayes;Saidi Kapiga;Nancy Padian;Sheena McCormack;Judith Wasserheit;

+ Author Information


    loading  Checking for direct PDF access through Ovid

Abstract

Previous papers in this supplement have reviewed the evidence of the effectiveness of alternative HIV prevention methods from randomized controlled trials and other studies. This paper draws together the main conclusions from these reviews. A conceptual framework is presented that maps the proximal and distal determinants of sexual HIV transmission and helps to identify the stages in the causal pathway at which each intervention approach acts. The advances, gaps and challenges emerging from the reviews of individual intervention methods are summarized and cross-cutting themes identified. Approximately 90% of HIV prevention trials have found no effect on HIV incidence and we explore the alternative explanations for the large number of ‘flat’ trials. We conclude that there is no single explanation for these flat results, which may be due to interventions that are ineffective or inappropriately targeted or implemented, or to factors related to the design or conduct of trials. We examine the lessons from these flat results and provide recommendations on what should be done differently in future trials. HIV prevention remains of critical importance in an era of expanded delivery of antiretroviral therapy. In future HIV prevention research, it is important that resources are used as efficiently as possible to provide rigorous evidence of the effectiveness of a wider array of complementary prevention tools.

Related Topics

    Related Articles

        loading  Loading Related Articles